| アブストラクト | BACKGROUND: Bipolar and other psychiatric disorders are associated with considerably increased risk of suicidal behaviour, which may include self-poisoning with medication used to treat the disorder. Therefore, choice of medication for treatment should include consideration of toxicity, especially for patients at risk. The aim of this study was to estimate the relative toxicity of specific drugs within two drug categories, antipsychotics and mood stabilizers, using large-scale databases to provide evidence that could assist clinicians in making decisions about prescribing, especially for patients at risk of suicidal behaviour. METHOD: Two indices were used to assess relative toxicity of mood stabilisers and antipsychotics: case fatality (the ratio between rates of fatal and non-fatal self-poisoning) and fatal toxicity (the ratio between rates of fatal self-poisoning and prescription). Mood stabilisers assessed included lithium [reference], sodium valproate, carbamazepine, and lamotrigine, while antipsychotics included chlorpromazine [reference], clozapine, olanzapine, quetiapine and risperidone. Fatal self-poisoning (suicide) data were provided by the Office for National Statistics (ONS), non-fatal self-poisoning data by the Multicentre Study of Self-harm in England, and information on prescriptions by the Clinical Practice Research Datalink. The primary analysis focussed on deaths due to a single drug. Cases where the drug of interest was listed as the likely primary toxic agent in multiple drug overdoses were also analysed. The study period was 2005-2012. RESULTS: There appeared to be little difference in toxicity between the mood stabilisers, except that based on case fatality where multiple drug poisonings were considered, carbamazepine was over twice as likely to result in death relative to lithium (OR 2.37 95% CI 1.16-4.85). Of the antipsychotics, clozapine was approximately18 times more likely to result in death when taken in overdose than chlorpromazine (single drug case fatality: OR 18.53 95% CI 8.69-39.52). Otherwise, only risperidone differed from chlorpromazine, being less toxic (OR 0.06 95% CI 0.01-0.47). CONCLUSIONS: There was little difference in toxicity of the individual mood stabilisers. Clozapine was far more toxic than the other antipsychotics. The findings are relevant to prescribing policy, especially for patients at particular risk of suicidal behaviour. |
|---|
| ジャーナル名 | BMC psychiatry |
|---|
| Pubmed追加日 | 2018/12/28 |
|---|
| 投稿者 | Ferrey, Anne E; Geulayov, Galit; Casey, Deborah; Wells, Claudia; Fuller, Alice; Bankhead, Clare; Ness, Jennifer; Clements, Caroline; Gunnell, David; Kapur, Navneet; Hawton, Keith |
|---|
| 組織名 | Centre for Suicide Research, Department of Psychiatry, University of Oxford,;Warneford Hospital, Oxford, UK. anne.ferrey@phc.ox.ac.uk.;Nuffield Department of Primary Care Health Sciences, University of Oxford,;Oxford, UK. anne.ferrey@phc.ox.ac.uk.;Warneford Hospital, Oxford, UK.;Office for National Statistics, Newport, UK.;Oxford, UK.;Centre for Self-harm and Suicide Prevention Research, Derbyshire Healthcare NHS;Foundation Trust, Derby, UK.;Centre for Suicide Prevention, University of Manchester, Manchester, UK.;School of Social and Community Medicine, University of Bristol, Bristol, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/30587176/ |
|---|
